ANTI-PD-1 ANTIBODIES FOR TREATMENT OF LUNG CANCER

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

Petra Rietschel,Israel Lowy

申请号：

US16486688

公开号：

US20200010550A1

申请日:

2018.02.20

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., lung cancer). The methods of the present invention comprise administering a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody), to a subject with lung cancer wherein the cancer tissue expresses PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/